North America Home Infusion Therapy Market Size, Trends, Competitors Strategy, Regional Analysis and Growth by Forecast to 2028

 The North America home infusion therapy market is expected to grow from US$ 10,954.08 million in 2022 to US$ 18,112.18 million by 2028. It is estimated to grow at a CAGR of 8.7% from 2022 to 2028

Increasing Incidences of Chronic Disorders Coupled with Rising Geriatric Population is Driving North America Home Infusion Therapy Market

Chronic disorders such as cardiovascular, nutritional, and gastrointestinal disorders, rheumatoid arthritis, and neurological disorders affect the overall quality of life.

๐Ÿ“š ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ@ https://www.businessmarketinsights.com/sample/BMIRE00028375

According to the World Health Organization (WHO), over 50% of the global population is estimated to suffer from at least one chronic disease. The Centers for Disease Control and Prevention (CDC) stated that 6 out of 10 people in the US suffered from at least one chronic disease in 2019. According to the “Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study,” a large-scale multinational study published in 2021, ~40% of 73,076 adults surveyed from 33 countries in the world were suffering from a functional gastrointestinal disorder (GFID). Age-related gastrointestinal problems are more common in the elderly population, aged 64 and above.

๐Ÿ“š๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‹๐ข๐ง๐ค @ https://www.businessmarketinsights.com/reports/north-america-home-infusion-therapy-market

๐“๐ก๐ž ๐‹๐ข๐ฌ๐ญ ๐จ๐Ÿ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ

B. Braun Melsungen AG

Baxter International Inc

Nipro Corp

Becton Dickinson and Co

Fresenius Kabi AG

ICU Medical Inc

JMS Co Ltd

Eitan Medical Ltd

Terumo Corp

Home Infusion Therapy Market: Delivering Healthcare Beyond Hospital Walls

The home infusion therapy market represents a dynamic and rapidly expanding segment within the broader healthcare landscape. It involves the administration of medications and therapies intravenously or subcutaneously to patients in the comfort and convenience of their homes, rather than in a hospital or clinic setting. This shift towards home-based care is driven by a confluence of factors, including technological advancements, cost-containment pressures, and a growing patient preference for personalized and convenient healthcare.  

Core Services and Therapies:

Home infusion therapy encompasses a wide range of services and therapies, catering to diverse patient needs.

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

 

๐€๐ฎ๐ญ๐ก๐จ๐ซ’๐ฌ ๐๐ข๐จ:

๐€๐ค๐š๐ฌ๐ก๐š ๐†๐ก๐š๐ซ๐ ๐ž

๐’๐ž๐ง๐ข๐จ๐ซ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐„๐ฑ๐ฉ๐ž๐ซ๐ญ

Comments

Post a Comment

Popular posts from this blog

3D and 4D Technology Market Trends, Size, Share, Growth, Analysis, Forecast to 2031

  The 3D and 4D Technology Market size is expected to reach US$ 1100.92 billion by 2031 from US$ 341.84 billion in 2024. The market is estimated to record a CAGR of 18.2% from 2024 to 2031.   Executive Summary and Global Market Analysis: The Ascendance of 3D and 4D Technologies Introduction: The realm of visual and interactive experiences is undergoing a profound transformation, driven by the rapid evolution of 3D and 4D technologies. These advancements are not merely incremental; they represent a fundamental shift in how we perceive and interact with digital content, bridging the gap between the virtual and the real. 3D technology, by its very nature, introduces depth and volume, moving beyond the flatness of traditional 2D displays. 4D technology, building upon this foundation, adds the critical dimension of time and sensory interaction, creating truly immersive and dynamic experiences. ๐Ÿ“š ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‹๐ข๐ง๐ค @ https://www.businessmarketinsights.com/...
Read more

North America Medical Tubing Market Analytical Overview, Comprehensive Analysis, Segmentation, Poised for Rapid Growth 2028

The North America medical tubing market is expected to grow from US$ 4,753.37 million in 2022 to US$ 6,936.79 million by 2028. It is estimated to record a CAGR of 6.5% from 2022 to 2028.   Increase in Number of Patients Requiring Tube Feeding Drives North America Medical Tubing Market A feeding tube is used to provide nutrients to patients who don’t get enough nutrition from ingested food. A medical tube is inserted in the stomach or small intestine to deliver liquid nutrition directly. ๐Ÿ“š ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ@ https://www.businessmarketinsights.com/sample/BMIRE00028042 Tube feeding procedure is prescribed to patients suffering from gastrointestinal dysfunction, head and neck cancer (which make swallowing difficult), neurological disorders such as stroke and paralysis, and other medical conditions. Crohn’s disease, a gastrointestinal disease associated with trauma; bowel obstruction (BO); microscopic colitis; short bowel syndrome; and ulcerati...
Read more

North America Ventilators Market Regional Share, Global Size, Trends, Segmentation and Forecast to 2028

The North America ventilators market is expected to grow from US$ 2,053.28 million in 2022 to US$ 3,525.60 million by 2028; it is estimated to register a CAGR of 9.4% from 2022 to 2028. Growing Prevalence of Respiratory Diseases Fuels North America Ventilators Market Respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, acute lower respiratory tract infections, tuberculosis, and lung cancer are among the most common causes of severe illness and death across North America. Urbanization, rise in pollution, unhealthy lifestyle habits, and high tobacco smoking prevalence are a few of the major factors leading to the surge in the number of respiratory and cardiovascular disease cases. ๐Ÿ“š ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ@ https://www.businessmarketinsights.com/sample/BMIRE00028250 Such disease can cause acute respiratory failure, and its treatment requires mechanical ventilation. As per the Office of Disease Prevention and Health Promotio...
Read more